HL7 and FHIR define how healthcare data is structured and exchanged between systems. MCP sits one layer higher and defines how AI agents discover tools, request actions, receive responses, and preserve context across workflows. In regulated environments, MCP can wrap HL7 or FHIR APIs so AI interacts through controlled, auditable access rather than direct ad hoc connections.
How MCP and HL7/FHIR differ at the integration layer
HL7 and FHIR are healthcare interoperability standards. They describe the shape of clinical and administrative data, how that data is encoded, and how systems exchange it. MCP is not trying to replace those standards. It sits above them, giving an AI agent a standard way to discover tools, request actions, and keep context while it works across those existing healthcare APIs.
The practical difference is the layer of abstraction. HL7 and FHIR answer, “How do two health systems exchange data safely and consistently?” MCP answers, “How should an agent interact with tools that may themselves expose HL7, FHIR, or other APIs?” That makes MCP useful for orchestration, while HL7 and FHIR remain the underlying data and interoperability contracts.
This distinction matters because a healthcare workflow often needs both. A lab system may publish FHIR resources, an EHR may consume them, and an AI assistant may sit in front of both. In that design, FHIR carries the record structure, while MCP governs how the agent reaches the function that reads, writes, or summarizes the record.
Why MCP changes the control model for AI access to healthcare systems
MCP changes the integration model from direct, custom agent connections to a controlled tool layer. That matters when the consuming system is autonomous or semi-autonomous, because the security question is no longer only data exchange, but also which actions the agent can invoke, under what authorization, and with what audit trail.
That is why MCP is often paired with gateway or broker patterns. Instead of allowing an AI agent to call a FHIR endpoint directly with broad credentials, teams can constrain the agent to approved tools that mediate the transaction, validate requests, and log activity. The healthcare standard still governs the payload, but MCP governs the interaction pattern around it.
For regulated environments, the useful mental model is “data contract versus action contract.” HL7 and FHIR are about the former. MCP is about the latter. If you need structured interoperability between EHRs, labs, payers, or registries, HL7/FHIR remain the core standards. If you need a governed interface for an AI system that is planning, querying, or taking workflow actions, MCP becomes the orchestration layer.
Where the distinction matters in real deployments
In practice, the most important difference is not technical elegance, but blast radius. A direct integration to healthcare APIs can be tightly scoped, but it still tends to embed each system relationship into custom code paths. MCP creates a more uniform access pattern for tools, which makes it easier to centralize policy, but it also means the MCP layer becomes a critical trust boundary that must be designed carefully.
That is especially important where AI systems operate across multiple back-end services. The agent should not be treated as a trusted peer of every healthcare system it can reach. It should be treated as a consumer of tools with narrowly defined permissions, clear authorization rules, and observable behavior. Standards like Model Context Protocol: Authorization specification describe that control plane more directly than HL7 or FHIR do.
For the AI side of the problem, the main issue is not whether the payload is FHIR-compliant, but whether the agent can be induced to misuse the tool chain, exceed intended privileges, or pass data into an unsafe action path. That is why healthcare teams evaluating MCP often also review OWASP Agentic AI Top 10 and the MCP Security Guide alongside the healthcare interoperability stack.
Risk and Threat Considerations
When MCP is used in front of HL7 or FHIR systems, the main risk is confusing data interoperability with access governance. A clean data schema does not prevent an AI agent from making an unauthorized or overbroad request if the tool layer is weakly controlled.
Failure mechanism: An MCP tool, gateway, or token flow can become the point where excessive privilege, token misuse, unsafe delegation, or tool confusion turns a safe-looking API into an unsafe action path.
Impact: The result can be unauthorized record access, incorrect workflow actions, wider-than-intended data exposure, or a governance gap where the system can explain the data exchange but not defend the decision to perform it.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
OWASP Agentic AI Top 10 and OWASP API Security Top 10 address the attack and risk surface, while NIST SP 800-53 Rev 5 and NIST Zero Trust (SP 800-207) set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| OWASP Agentic AI Top 10 | ASI03 — Identity & Privilege Abuse | MCP-mediated agents need scoped authority over healthcare tools and APIs. |
| Recommendation — Constrain agent tool access and privileges before allowing clinical workflow actions. | ||
| OWASP API Security Top 10 | API5 — Broken Function Level Authorization | MCP can front healthcare APIs, making function-level authorization a central control point. |
| Recommendation — Enforce function-level authorization on every healthcare API action. | ||
| NIST SP 800-53 Rev 5 | IA-9 — Service Authentication | MCP and backend healthcare services rely on authenticated non-human access paths. |
| AU-2 — Event Logging | MCP-mediated healthcare actions need traceable, auditable tool use. | |
| Recommendation — Authenticate service-to-service calls before exposing FHIR or HL7 tooling. Log agent tool requests and responses for audit and review. | ||
| NIST Zero Trust (SP 800-207) | Zero Trust Architecture | A brokered MCP layer fits zero-trust principles for limiting implicit trust in agents. |
| Recommendation — Place the agent behind explicit policy checks instead of trusting network location. | ||
Practitioner Guidance
What to prioritise: Separate the interoperability question from the authorization question. HL7 and FHIR define what the systems say to each other; MCP defines how the agent is allowed to ask, act, and remain in context.
What to verify: Check whether the agent has direct API reach, delegated tool access, or brokered access through an MCP server. If it can touch healthcare data or workflow actions, confirm the authorization boundary and logging path before approving the design.
Common mistake: Treating FHIR compliance as if it automatically makes an AI integration safe. Compliance with the data format does not by itself constrain the agent’s action scope, privilege, or operational blast radius.
Practitioner takeaway: Use HL7 and FHIR to standardize healthcare data exchange, and use MCP only when you need a governed agent interaction layer on top of that exchange.
Related resources from NHI Mgmt Group
- What is the difference between a read only MCP connector and a traditional security integration that can change records?
- What is the difference between MCP and a traditional local integration for security investigations?
- What is the difference between MCP access and ordinary app integration?
- What is the difference between MCP integration and normal API integration?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 30, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
